# Chronic TBPH Exposure Drives the Transition from Steatosis to Hepatic Fibrosis via Lipid Droplet Dysregulation in Zebrafish

**Authors:** Yiming Liu, Dingxi Pan, Mingying Li, Wei Guo

PMC · DOI: 10.3390/biology15060463 · Biology · 2026-03-13

## TL;DR

Chronic exposure to TBPH causes liver damage in zebrafish by disrupting lipid balance and leading to fibrosis.

## Contribution

This study reveals a novel mechanism linking chronic TBPH exposure to the progression of liver disease via lipid droplet dysregulation.

## Key findings

- Chronic TBPH exposure leads to macrovesicular steatosis and hepatic fibrosis in zebrafish.
- TBPH disrupts lipid balance by stimulating DGAT2-mediated triglyceride synthesis and promoting lipid droplet expansion.
- Proteomic analysis identified Mfap4 as a key protein associated with fibrosis and extracellular matrix remodeling.

## Abstract

This study provides compelling evidence that chronic exposure to TBPH acts as a potent environmental disruptor of hepatic homeostasis, driving the progression from simple steatosis to fibrotic steatohepatitis in zebrafish. We demonstrate that TBPH disrupts the critical balance between hepatic lipid acquisition and expenditure. Mechanistically, this imbalance is mediated by dysregulated lipid droplet biogenesis leading to the formation of enlarged lipid droplets, which has been validated in vitro. This unresolved lipid burden subsequently triggers a transition toward a chronic inflammatory state and fibrosis. Moreover, we identified the significant upregulation of key fibrotic drivers in the high-concentration exposure group. Collectively, these findings elucidate a distinct mechanism where long-term TBPH exposure exacerbates liver injury beyond the capacity of metabolic adaptation.

Bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (TBPH) is a widely used novel flame retardant and an emerging ubiquitous environmental contaminant. While acute exposure disrupts lipid signaling, the long-term consequences of TBPH exposure on the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) remain poorly understood. This study aimed to elucidate the chronic hepatotoxic effects of TBPH and the underlying molecular mechanisms. Adult zebrafish were exposed to environmentally relevant concentrations of TBPH for 6 weeks. Hepatic damage was assessed using histological examination, biochemical assays, and integrated proteomic and transcriptomic profiling. In vitro assays using HepG2 cells were conducted to validate cellular mechanisms of lipid droplet (LD) dynamics. Chronic TBPH exposure induced severe macrovesicular steatosis and significant hepatic fibrosis in zebrafish. Transcriptional analysis revealed that TBPH activated both lipid synthesis and fatty acid oxidation. In vitro results confirmed that TBPH stimulated DGAT2-mediated triglyceride synthesis and promoted LD expansion via ER-LD co-localization. Proteomic analysis identified a microfibril-associated protein 4 (Mfap4) associated with extracellular matrix remodeling and fibrosis. These findings demonstrate that chronic TBPH exposure acts as a potent metabolic disruptor, driving a pathological cascade from steatosis to fibrosis. This study provides a comprehensive adverse outcome pathway for TBPH-induced hepatotoxicity, highlighting its potential role in the etiology of metabolic dysfunction-associated steatohepatitis.

## Linked entities

- **Genes:** DGAT2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 84649], MFAP4 (microfibril associated protein 4) [NCBI Gene 4239]
- **Proteins:** MFAP4 (microfibril associated protein 4)
- **Chemicals:** TBPH (PubChem CID 117291), triglyceride (PubChem CID 5460048)
- **Diseases:** metabolic dysfunction-associated steatotic liver disease (MONDO:0013209)
- **Species:** Danio rerio (taxon 7955)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, actb1 (actin, beta 1) [NCBI Gene 57934] {aka ACTB, B-ACTZF, actba, bact, bactin1, bactzf}, PLIN5 (perilipin 5) [NCBI Gene 440503] {aka LSDA5, LSDP5, MLDP, OXPAT}, mfn1b (mitofusin 1b) [NCBI Gene 393620] {aka mfn1, zgc:66150}, mfap4.1 (microfibril associated protein 4, tandem duplicate 1) [NCBI Gene 405825] {aka mfap4, zgc:77076}, fasn (fatty acid synthase) [NCBI Gene 559001] {aka fj34h12, wu:fj34h12}, CIDEA (cell death inducing DFFA like effector a) [NCBI Gene 1149] {aka CIDE-A}, apoa1a (apolipoprotein A-Ia) [NCBI Gene 30355] {aka Apo-AIa, ApoA-Ia, apoa, apoa1, cb49, wu:fb33f01}, acaca (acetyl-CoA carboxylase alpha) [NCBI Gene 559403] {aka acc, fj43d01, im:7138837, si:ch211-199d18.1, wu:fj43d01}, cidea (cell death inducing DFFA like effector a) [NCBI Gene 100536460] {aka si:ch211-9a18.4}, pparg (peroxisome proliferator-activated receptor gamma) [NCBI Gene 557037] {aka PPAR[g]}, pparaa (peroxisome proliferator-activated receptor alpha a) [NCBI Gene 563298] {aka ppara3, si:ch211-239e6.3}, ppargc1a (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) [NCBI Gene 553418] {aka PGC-1, PGC-1alpha, PGC1, gb:dq017637, ppargc1al}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, fabp4a (fatty acid binding protein 4a) [NCBI Gene 447944] {aka fabp11, fabp11a, zgc:103587}, DGAT2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 84649] {aka ARAT, GS1999FULL, HMFN1045}, srebf2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 100037309] {aka zgc:158371}, MFAP4 (microfibril associated protein 4) [NCBI Gene 4239], PDIA3 (protein disulfide isomerase family A member 3) [NCBI Gene 2923] {aka ER60, ERp57, ERp60, ERp61, GRP57, GRP58}, foxo1a (forkhead box O1 a) [NCBI Gene 768121] {aka FoxO1a.1, foxo1, zgc:153388}, cpt1aa (carnitine palmitoyltransferase 1Aa (liver)) [NCBI Gene 558088] {aka cpt1a, si:dkey-56p7.8}, plin2 (perilipin 2) [NCBI Gene 794841] {aka adfp, zgc:110411}, PLIN2 (perilipin 2) [NCBI Gene 123] {aka ADFP, ADRP}, tnfa (tumor necrosis factor a (TNF superfamily, member 2)) [NCBI Gene 405785], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, meltf (melanotransferrin) [NCBI Gene 565942] {aka im:7143617, mfi2}, dgat2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 565316] {aka ARAT, zgc:113394}
- **Diseases:** obesity (MESH:D009765), T2DM (MESH:D003924), TBPH (MESH:D020803), collagen (MESH:D003095), Fibrosis (MESH:D005355), chronic (MESH:D002908), insulin resistance (MESH:D007333), injury to (MESH:D014947), Hepatic damage (MESH:D056486), metabolic dysfunction (MESH:D008659), Steatosis (MESH:D005234), chronic liver inflammation (MESH:D007249), Hepatic Fibrosis (MESH:D008103), mitochondrial dysfunction (MESH:D028361), metabolic syndrome (MESH:D024821), liver injury (MESH:D017093), lipid metabolic disorder (MESH:D052439), cytotoxicity (MESH:D064420), hepatic lipid accumulation (MESH:D011017), MASLD (MESH:D008107)
- **Chemicals:** Leads (MESH:D007854), palmitic acid (MESH:D019308), penicillin (MESH:D010406), DMSO (MESH:D004121), Bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (MESH:C576262), peptides (MESH:D010455), fatty acid (MESH:D005227), Chemicals (-), paraffin (MESH:D010232), linoleic acid (MESH:D019787), formaldehyde (MESH:D005557), streptomycin (MESH:D013307), NaCl (MESH:D012965), Lipid (MESH:D008055), glucose (MESH:D005947), nitrogen (MESH:D009584), MS-222 (MESH:C003636), TRIzol (MESH:C411644), OA (MESH:D019319), triglyceride (MESH:D014280), TEAB (MESH:C041737), DTT (MESH:D004229), hematoxylin (MESH:D006416), CO2 (MESH:D002245), IAM (MESH:D007460), ATP (MESH:D000255), acetyl-CoA (MESH:D000105), paraformaldehyde (MESH:C003043), SDS (MESH:D012967), DAPI (MESH:C007293), malonyl-CoA (MESH:D008316), oleic acid (MESH:D019301)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023650/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023650/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023650/full.md

---
Source: https://tomesphere.com/paper/PMC13023650